Stock comparison
Globus Medical
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GMED
Globus Medical
Market cap
$11.44B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GMED | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 58C | 72B | LLY |
| Benjamin Graham | 65B | 86A | LLY |
| Philip Fisher | 70C | 86A | LLY |
| Peter Lynch | 63C | 74B | LLY |
| Joel Greenblatt | 45D | 78C | LLY |
| Charlie Munger | 51D | 85A | LLY |
| Terry Smith | 56D | 77C | LLY |
Side-by-side metrics
| Metric | GMED | LLY |
|---|---|---|
| Market cap | $11.44B | $1T |
| P/E (TTM) | 17.7x | 36.6x |
| EV/EBIT | 20.6x | 34.1x |
| ROIC (TTM) | 9.72% | 32.06% |
| Gross margin | 67.86% | 83.51% |
| Net margin | 18.92% | 34.98% |
| Revenue CAGR 5y | 32.34% | 23.17% |
| EPS CAGR 5y | 28.06% | 40.81% |
| Debt / Equity | 0.0x | 1.4x |
| Dividend yield | 0.0% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GMED leads on
- Debt / Equity0.0xvs 1.4x+98%
- P/E (TTM)17.7xvs 36.6x+52%
- EV/EBIT20.6xvs 34.1x+40%
- Revenue CAGR 5y32.34%vs 23.17%+28%
LLY leads on
- Dividend yield0.62%vs 0.0%+100%
- Market cap$1Tvs $11.44B+99%
- ROIC (TTM)32.06%vs 9.72%+70%
- Net margin34.98%vs 18.92%+46%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.